169 related articles for article (PubMed ID: 10077177)
1. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study.
Pezzotti P; Galai N; Vlahov D; Rezza G; Lyles CM; Astemborski J
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):275-82. PubMed ID: 10077177
[TBL] [Abstract][Full Text] [Related]
2. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
Prins M; Veugelers PJ
AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
[TBL] [Abstract][Full Text] [Related]
3. Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.
Rezza G
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 17 Suppl 1():S13-6. PubMed ID: 9586645
[TBL] [Abstract][Full Text] [Related]
4. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
[TBL] [Abstract][Full Text] [Related]
5. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
[TBL] [Abstract][Full Text] [Related]
8. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.
AIDS; 1992 Apr; 6(4):421-6. PubMed ID: 1616637
[TBL] [Abstract][Full Text] [Related]
9. [AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort].
Pérez-Hoyos S; Aviñó M; Hernández I; González J; Ruiz I
Gac Sanit; 1999; 13(5):337-45. PubMed ID: 10564846
[TBL] [Abstract][Full Text] [Related]
10. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
Prins M; Hernández Aguado IH; Brettle RP; Robertson JR; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
AIDS; 1997 Nov; 11(14):1747-56. PubMed ID: 9386810
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. Italian HIV Seroconversion Study (ISS).
Dorrucci M; Balducci M; Pezzotti P; Sinicco A; Alberici F; Rezza G
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):65-70. PubMed ID: 10534148
[TBL] [Abstract][Full Text] [Related]
12. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion.
Spijkerman IJ; Langendam MW; Veugelers PJ; van Ameijden EJ; Keet IP; Geskus RB; van den Hoek A; Coutinho RA
Epidemiology; 1996 Nov; 7(6):571-7. PubMed ID: 8899381
[TBL] [Abstract][Full Text] [Related]
13. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
Prins M; Brettle RP; Robertson JR; Hernández Aguado I; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
Int J Epidemiol; 1999 Jun; 28(3):541-9. PubMed ID: 10405862
[TBL] [Abstract][Full Text] [Related]
14. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group.
Pezzotti P; Phillips AN; Dorrucci M; Lepri AC; Galai N; Vlahov D; Rezza G
BMJ; 1996 Sep; 313(7057):583-6. PubMed ID: 8806246
[TBL] [Abstract][Full Text] [Related]
15. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.
Hessol NA; Koblin BA; van Griensven GJ; Bacchetti P; Liu JY; Stevens CE; Coutinho RA; Buchbinder SP; Katz MH
Am J Epidemiol; 1994 Jun; 139(11):1077-87. PubMed ID: 8192140
[TBL] [Abstract][Full Text] [Related]
16. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.
Phillips AN; Pezzotti P; Lepri AC; Rezza G
AIDS; 1994 Sep; 8(9):1299-305. PubMed ID: 7802984
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
[TBL] [Abstract][Full Text] [Related]
18. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004.
Grigoryan A; Hall HI; Durant T; Wei X
PLoS One; 2009; 4(2):e4445. PubMed ID: 19214229
[TBL] [Abstract][Full Text] [Related]
19. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users.
Galai N; Margolick JB; Astemborski J; Vlahov D
Clin Immunol Immunopathol; 1996 May; 79(2):134-41. PubMed ID: 8620619
[TBL] [Abstract][Full Text] [Related]
20. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
Alcabes P; Muñoz A; Vlahov D; Friedland G
Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
